Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanna M Hieromnimon

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nature Cancer|June 28, 2022
Ovarian cancer through a multi-modal lensHanna M Hieromnimon, Alexander T Pearson
Biorxiv : the Preprint Server for Biology|June 9, 2023
Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosisKiranj Chaudagar, Hanna M Hieromnimon, Anne Kelley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2023
Suppression of Tumor Cell Lactate-generating Signaling Pathways Eradicates Murine PTEN/p53-deficient Aggressive-variant Prostate Cancer via Macrophage PhagocytosisKiranj Chaudagar, Hanna M Hieromnimon, Anne Kelley, et al.
Science Advances|November 15, 2024
Generative adversarial networks accurately reconstruct pan-cancer histology from pathologic, genomic, and radiographic latent featuresFrederick M Howard, Hanna M Hieromnimon, Siddhi Ramesh, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Generative Adversarial Networks Accurately Reconstruct Pan-Cancer Histology from Pathologic, Genomic, and Radiographic Latent FeaturesFrederick M Howard, Hanna M Hieromnimon, Siddhi Ramesh, et al.
Genome Medicine|August 8, 2025
Building digital histology models of transcriptional tumor programs with generative deep learning for pathology-based precision medicineHanna M Hieromnimon, James Dolezal, Kristina Doytcheva, et al.
Molecular Cancer Therapeutics|December 5, 2020
Cabozantinib Unlocks Efficient <i>In Vivo</i> Targeted Delivery of Neutrophil-Loaded Nanoparticles into Murine Prostate TumorsKiranj Kishor Chaudagar, Natalie Landon-Brace, Aniruddh Solanki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2023
Reversal of Lactate and PD-1-mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate CancerKiranj Chaudagar, Hanna M Hieromnimon, Rimpi Khurana, et al.
NPJ Precision Oncology|May 29, 2023
Deep learning generates synthetic cancer histology for explainability and educationJames M Dolezal, Rachelle Wolk, Hanna M Hieromnimon, et al.
Oral Oncology|March 5, 2025
Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomasHanna M Hieromnimon, Anna Trzcinska, Frank T Wen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nature Cancer|June 28, 2022
Ovarian cancer through a multi-modal lensHanna M Hieromnimon, Alexander T Pearson
Biorxiv : the Preprint Server for Biology|June 9, 2023
Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosisKiranj Chaudagar, Hanna M Hieromnimon, Anne Kelley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2023
Suppression of Tumor Cell Lactate-generating Signaling Pathways Eradicates Murine PTEN/p53-deficient Aggressive-variant Prostate Cancer via Macrophage PhagocytosisKiranj Chaudagar, Hanna M Hieromnimon, Anne Kelley, et al.
Science Advances|November 15, 2024
Generative adversarial networks accurately reconstruct pan-cancer histology from pathologic, genomic, and radiographic latent featuresFrederick M Howard, Hanna M Hieromnimon, Siddhi Ramesh, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Generative Adversarial Networks Accurately Reconstruct Pan-Cancer Histology from Pathologic, Genomic, and Radiographic Latent FeaturesFrederick M Howard, Hanna M Hieromnimon, Siddhi Ramesh, et al.
Genome Medicine|August 8, 2025
Building digital histology models of transcriptional tumor programs with generative deep learning for pathology-based precision medicineHanna M Hieromnimon, James Dolezal, Kristina Doytcheva, et al.
Molecular Cancer Therapeutics|December 5, 2020
Cabozantinib Unlocks Efficient <i>In Vivo</i> Targeted Delivery of Neutrophil-Loaded Nanoparticles into Murine Prostate TumorsKiranj Kishor Chaudagar, Natalie Landon-Brace, Aniruddh Solanki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2023
Reversal of Lactate and PD-1-mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate CancerKiranj Chaudagar, Hanna M Hieromnimon, Rimpi Khurana, et al.
NPJ Precision Oncology|May 29, 2023
Deep learning generates synthetic cancer histology for explainability and educationJames M Dolezal, Rachelle Wolk, Hanna M Hieromnimon, et al.
Oral Oncology|March 5, 2025
Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomasHanna M Hieromnimon, Anna Trzcinska, Frank T Wen, et al.
Pageof 2